Brady Allison W 4

What Happened
Allison W. Brady, a director of Jupiter Neurosciences, was granted 100,000 options (reported as a derivative award) on June 2, 2026. The filing shows an acquisition at $0.00 per share (acquisition value $0). This is a compensation award (not an open-market purchase or sale).

Key Details

• Transaction date: June 2, 2026; Form 4 filed June 5, 2026.
• Transaction type: Grant/Award (code A) of 100,000 options; exercise price reported $0.00; acquisition value $0.
• Vesting: Per footnote, the options were granted under the 2025 Equity Incentive Plan and vest over three years starting September 2, 2026 in equal quarterly installments, subject to continued service.
• Shares owned after transaction: Not specified in the provided filing.
• Timeliness: Form filed three days after the transaction date; no late-filing flag was noted in the supplied record.

Context
These are time‑based equity awards that will convert into exercisable shares only as they vest; there was no immediate cash exchange or sale of shares. Grants to directors are a common form of compensation and do not by themselves indicate buying or selling sentiment in the open market.